VYGLXIA Trademark
VYGLXIA is a USPTO trademark filed by Biohaven Therapeutics Ltd.. Status: Registered.
Trademark Facts
| Mark | VYGLXIA |
|---|---|
| Serial Number | 90605911 |
| Registration Number | 7422444 |
| Status | Registered |
| Filing Date | 2021-03-26 |
| Registration Date | 2024-06-18 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Biohaven Therapeutics Ltd. |
| Attorney of Record | Monica Riva Talley |
| Prosecution Events | 42 |
| Latest Event | NRCC on 2024-06-18 |
Goods & Services
Medicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans and animals, namely, for the treatment of central nervous system disorders, neurologic illnesses, and psychiatric illnesses; pharmaceutical preparations for the treatment of neurodegenerative diseases; pharmaceutical preparations for the treatment of neurodegenerative diseases, namely, Alzheimer's disease (AD), frontotemporal dementia, and cognitive impairment of aging; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of pain, namely, chronic neuropathic pain and peripheral neuropathy; pharmaceutical preparations for symptomatic treatments of degenerative diseases; pharmaceutical preparations for symptomatic treatments of degenerative diseases, namely, dystonias, dysphagia, gait abnormalities, bulbar function in ALS, agitation in AD, and disinhibition in dementia; pharmaceutical preparations for the treatment of neuropsychiatric disorders; pharmaceutical preparations for the treatment of neuropsychiatric disorders, namely, Obsessive Compulsive Disorder (OCD) and Generalized Anxiety Disorder (GAD); pharmaceutical preparations for the treatment of cerebellar disorders; pharmaceutical preparations for the treatment of cerebellar disorders, namely, spinocerebellar ataxia